Literature DB >> 10644876

Animal models of Alport syndrome: advancing the prospects for effective human gene therapy.

P Heikkilä1, K Tryggvason, P Thorner.   

Abstract

Several animal models for Alport syndrome have been described. These are available for studies on the pathogenetic mechanisms of the disease, as well as for the development of new technologies for gene therapy in this progressive hereditary kidney disease. This review summarizes current knowledge on the molecular basis of Alport syndrome, and on the animal models which all remarkably well resemble the human disease. Recent work aimed at the development of gene therapy, including hurdles and progress are discussed. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644876     DOI: 10.1159/000020641

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


  4 in total

Review 1.  Focusing on the glomerular slit diaphragm: podocin enters the picture.

Authors:  Jeffrey H Miner
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

2.  Development of kidney glomerular endothelial cells and their role in basement membrane assembly.

Authors:  Dale R Abrahamson
Journal:  Organogenesis       Date:  2009-01       Impact factor: 2.500

3.  The inner ear of dogs with X-linked nephritis provides clues to the pathogenesis of hearing loss in X-linked Alport syndrome.

Authors:  S J Harvey; R Mount; Y Sado; I Naito; Y Ninomiya; R Harrison; B Jefferson; R Jacobs; P S Thorner
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

4.  Transplantation of umbilical cord mesenchymal stem cells into mice with focal segmental glomerulosclerosis delayed disease manifestation.

Authors:  Yifan Shi; Jingyuan Xie; Mingxin Yang; Jun Ma; Hong Ren
Journal:  Ann Transl Med       Date:  2019-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.